Eagle Global Advisors’s Biostar Pharmaceuticals, Inc. BSPM Stock Holding History

Eagle Global Advisors’s Portfolio BSPM Stock Details BSPM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	–	Sell	-2,940	Closed	-$33K	–	370
2014 Q3	$33K	Sell	2,940 -1,376	-32%	-$15.3K	﹤0.01%	335
2014 Q2	$44K	Buy	+4,316	New	+$47.7K	﹤0.01%	332

Other funds holding BSPM

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

SIM

Spark Investment Management New York $41.6M AUM 80.97% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Eagle Global Advisors's BSPM Position: Q4 2014 in Review

Eagle Global Advisors sold out of Biostar Pharmaceuticals, Inc. (BSPM) in Q4 2014, closing a stake of 2,940 shares — an estimated $33K sold.

Eagle Global Advisors first reported a position in BSPM in Q2 2014 and held it in 2 quarters. The position peaked at $44K in Q2 2014. 7 funds tracked by Wall St. Rank hold BSPM as of Q4 2014.

Eagle Global Advisors reported no remaining Biostar Pharmaceuticals, Inc. position as of Q4 2014 after selling out during the quarter.
Eagle Global Advisors sold 2,940 Biostar Pharmaceuticals, Inc. shares in Q4 2014, an estimated $33K.
Eagle Global Advisors first reported a position in Biostar Pharmaceuticals, Inc. in Q2 2014 and held it in 2 quarters.
Eagle Global Advisors's Biostar Pharmaceuticals, Inc. position peaked at $44K in Q2 2014.
7 funds tracked by Wall St. Rank held Biostar Pharmaceuticals, Inc. as of Q4 2014.

Based on Eagle Global Advisors's 13F filing for Q4 2014, filed 9 Feb 2015.